Category: Women’s Imaging

New Path to Treat Advanced Triple-Negative Breast Cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative breast cancer, one of the most difficult disease sub-types to treat.

Read More

The First AI Breast Cancer Sleuth That Shows Its Work?

Researchers have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, the algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.

Read More
Loading